Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 4:00 PM EDT

Vireo Growth (VREOF) Depreciation & Amortization (CF) (2020 - 2026)

Vireo Growth (VREOF) posted Depreciation & Amortization (CF) of $4.0 million for Q1 2026, down 66.43% sequentially from $11.9 million in Q4 2025, and up 566.67% YoY from $600000.0 in Q1 2025.

Vireo Growth (VREOF) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Vireo Growth has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $4.0 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 566.67% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 679.43% YoY) and the FY2025 annual result came in at $16.1 million, up 535.04% from the prior year.
  • Depreciation & Amortization (CF) retreated to $4.0 million in Q1 2026 per VREOF's latest filing, from $11.9 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $11.9 million in Q4 2025 and troughed at $600000.0 in Q1 2025.
  • A 5-year average of $1.7 million and a median of $776991.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) declined 29.08% in 2024, then soared 1774.66% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $889195.0 in 2022, then retreated by 26.84% to $650503.0 in 2023, then dropped by 2.29% to $635583.0 in 2024, then jumped by 1774.66% to $11.9 million in 2025, then sank by 66.43% to $4.0 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $4.0 million, $11.9 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Vireo Growth 482.88 Mn 340.58 Mn 95.30 Mn 5.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.00 Mn
Mar 31, 2026 4.00 Mn
Dec 31, 2025 11.92 Mn
Dec 31, 2025 11.92 Mn
Sep 30, 2025 2.34 Mn
Sep 30, 2025 2.34 Mn
Jun 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 600,000.00
Mar 31, 2025 600,000.00
Dec 31, 2024 635,583.00
Dec 31, 2024 635,583.00
Sep 30, 2024 633,586.00
Sep 30, 2024 633,586.00
Jun 30, 2024 633,884.00
Jun 30, 2024 633,884.00
Mar 31, 2024 633,728.00
Mar 31, 2024 633,728.00
Dec 31, 2023 650,503.00
Dec 31, 2023 650,503.00